# EDGAR Filing Document

**Accession Number:** 0001922335
**File Stem:** 0001641172-25-024383
**Filing Date:** 2025-8
**Character Count:** 4689
**Document Hash:** bb1ae96a622cc803cb0806d748d84b3c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-024383.hdr.sgml**: 20250815

**ACCESSION NUMBER**: 0001641172-25-024383

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250813

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20250815

**DATE AS OF CHANGE**: 20250815

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Syra Health Corp
- **CENTRAL INDEX KEY:** 0001922335
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EMPLOYMENT AGENCIES [7361]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41822
- **FILM NUMBER:** 251225127

**BUSINESS ADDRESS:**
- **STREET 1:** 1119 KEYSTONE WAY N.
- **STREET 2:** #201
- **CITY:** CARMEL
- **STATE:** IN
- **ZIP:** 46032
- **BUSINESS PHONE:** (317) 922-0922

**MAIL ADDRESS:**
- **STREET 1:** 1119 KEYSTONE WAY N.
- **STREET 2:** #201
- **CITY:** CARMEL
- **STATE:** IN
- **ZIP:** 46032

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **August 13, 2025**

**SYRA HEALTH CORP.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41822** | **85-4027995** |
| (State or other jurisdiction | (Commission | (I. R. S. Employer |
| of incorporation) | File Number) | Identification No.) |

---

**1119 Keystone Way N. #201**

**Carmel, IN 46032**

(Address of principal executive offices, including zip code)

**(463) 345-8950**

(Registrant's telephone number, including area code)

**Not Applicable** 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock, $0.001 par value | SYRA | OTCQB |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

---

| | |
|:---|:---|
| **Item 5.02.** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** |

---

On August 13, 2025, the Board of Directors of Syra Health Corp. (the "Company") appointed Radhika Mereddy as a member of the Board.

Ms. Mereddy's ongoing annual compensation will be consistent with that provided to the Company's other non-employee directors.

There is no arrangement or understanding between Ms. Mereddy and any other persons pursuant to which Ms. Mereddy was selected as a director. There are no related party transactions involving Ms. Mereddy that are reportable under Item 404(a) of Regulation S-K, except she is a principal stockholder in RAD CUBE LLC, STVentures, LLC, NLogix IT Services Private Limited and SKL Demand Private Limited.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SYRA HEALTH CORP.** | **SYRA HEALTH CORP.** |
| Date: August 15, 2025 | By: | */s/ Priya Prasad* |
|  |  | Priya Prasad<br> Interim Chief Executive Officer |

---